Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience

[1] Stein JP(2001)Radical cystectomy in the treatment of invasive bladder cancer. long-term results in patients J Clin Oncol 19 666-675

[2] Lieskovsky G(2016)Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: a 20-year single center experience Eur J Surg Oncol 42 735-743

[3] Cote R(2003)Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859-866

[4] Groshen S(2005)Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer meta-analysis collaboration Eur Urol 48 202-205

[5] Feng AC(2016)Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis Oncologist 21 708-715

[6] Boyd S(2007)P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors Eur Urol 52 769-774

[7] Moschini M(2012)Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 1229-1238

[8] Karnes RJ(2014)Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis Eur Urol 65 350-357

[9] Sharma V(2017)Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline J Urol 198 552-559

[10] Gandaglia G(2009)Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality J Natl Compr Canc Netw 7 40-47

[1] Stein JP(2001)Radical cystectomy in the treatment of invasive bladder cancer. long-term results in patients J Clin Oncol 19 666-675

[2] Lieskovsky G(2016)Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: a 20-year single center experience Eur J Surg Oncol 42 735-743

[3] Cote R(2003)Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859-866

[4] Groshen S(2005)Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer meta-analysis collaboration Eur Urol 48 202-205

[5] Feng AC(2016)Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis Oncologist 21 708-715

[6] Boyd S(2007)P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors Eur Urol 52 769-774

[7] Moschini M(2012)Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 1229-1238

[8] Karnes RJ(2014)Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis Eur Urol 65 350-357

[9] Sharma V(2017)Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline J Urol 198 552-559

[10] Gandaglia G(2009)Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality J Natl Compr Canc Netw 7 40-47